Topical naproxen sodium for inhibition of miosis during cataract surgery. Prospective, randomized clinical trials
- 28 May 2002
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Eye
- Vol. 16 (3), 292-296
- https://doi.org/10.1038/sj.eye.6700124
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- PROSTAGLANDIN INHIBITION AND CENTRAL CORNEAL THICKNESS AFTER CATARACT EXTRACTIONActa Ophthalmologica, 2009
- Naproxen ophthalmic solution to manage inflammation after phacoemulsificationJournal of Cataract & Refractive Surgery, 2002
- Preoperative and postoperative medications used for cataract surgeryCurrent Opinion in Opthalmology, 1999
- The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology.British Journal of Ophthalmology, 1996
- Effect of Sodium Naproxen on Inflammatory Response Induced by Anterior Chamber Paracentesis in the RabbitJournal of Pharmacy and Pharmacology, 1995
- Cyclo-oxygenase inhibitors in ophthalmologySurvey of Ophthalmology, 1992
- Effects of Sodium Naproxen Eye Drops on Rabbit Ocular Inflammation Induced by Sodium ArachidonateJournal of Ocular Pharmacology and Therapeutics, 1991
- Naproxen A Reappraisal of its Pharmacology, and Therapeutic Use in Rheumatic Diseases and Pain StatesDrugs, 1990
- THE EFFECT OF THE PROSTAGLANDIN‐INHIBITOR NAPROXEN ON THE ENDOTHELIAL CELL‐LOSS AFTER CATARACT EXTRACTIONActa Ophthalmologica, 1983
- Prostaglandin and eyeProstaglandins, 1973